Superworth

Nautilus Biotechnology EPS NAUT

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Sep 30, 2026
−$0.46
Latest quarter, Q3 FY26
−$0.12
Fiscal year 2025
−$0.47

Nautilus Biotechnology's earnings per share was −$0.46 over the twelve months to Sep 30, 2026.

In its latest quarter, Q3 FY26, it was −$0.12.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.47n/a
FY2024−$0.56n/a
FY2023−$0.52n/a
FY2022−$0.47n/a
FY2021−$0.69n/a
FY2020−$0.53n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26−$0.12n/a−$0.46
Q2 FY26−$0.11n/a−$0.45
Q1 FY26−$0.12n/a−$0.46
Q4 FY25−$0.11n/a−$0.47
Q3 FY25−$0.11n/a−$0.50
Q2 FY25−$0.12n/a−$0.52
Q1 FY25−$0.13n/a−$0.54
Q4 FY24−$0.14n/a−$0.56
Q3 FY24−$0.13n/a−$0.56
Q2 FY24−$0.14n/a−$0.56
Q1 FY24−$0.15n/a−$0.55
Q4 FY23−$0.14n/a−$0.52

Against its peers

Companies in Healthcare nearest Nautilus Biotechnology's size, closest first, today.

CompanyEPS, 12 monthsGrowth
NAUTNautilus Biotechnology−$0.46
CYHCommunity Health Systems$0.26−89% a year
INFUInfuSystem$0.41+78% a year
EMBCEmbecta$1.47+3% a year
VMDViemed Healthcare$0.36+6% a year
UTMDUtah Medical Products$3.28−12% a year
ELMDElectromed$1.31+56% a year
NATRNatures Sunshine Products$1.01+36% a year
CRMDCorMedix$2.13+184% a year
PLXProtalix BioTherapeutics$0.23+283% a year
PDEXPro DEX$3.63+8% a year
Peer median$1.16

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Nautilus Biotechnology

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.